HKSE - Delayed Quote HKD

Suzhou Basecare Medical Corporation Limited (2170.HK)

2.900
+0.050
+(1.75%)
At close: May 16 at 4:08:18 PM GMT+8
Loading Chart for 2170.HK
  • Previous Close 2.850
  • Open 2.850
  • Bid 2.900 x --
  • Ask 2.930 x --
  • Day's Range 2.850 - 2.920
  • 52 Week Range 1.290 - 4.450
  • Volume 23,500
  • Avg. Volume 159,344
  • Market Cap (intraday) 793.225M
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -0.970
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.93

Suzhou Basecare Medical Corporation Limited, an investment holding company provides genetic testing solutions for assisted human reproduction in the People's Republic of China and Australia. The company offers pre-implantation genetic test kits, including PGT-A kit to detect aneuploidy; PGT-M kit to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kit to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides DA500, a high-throughput gene sequencer that provides users with sequencing options; DA5000 high-throughput gene sequencer which provides one-stop genetic laboratory solution for assisted reproductive centers; BS1000C, a high-throughput automated sample preparation system; PGT-A, PGT-M, and PGT-SR analysis software; Geri, a Time-Lapse Incubator to provide safe and stable culture conditions for embryo culturing; and collection of culture media. In addition, the company offers BCT38, a liquid nitrogen storage dewar with a digital management system; BSG800A and BSG800C, a cryopreservation system; BKA210, a Sperm quality analyzer; Self Sperm Testing Device; Gavi, an automated vitrification instrument for the process of freezing embryos and eggs in the IVF automated vitrification; Intelligent assisted reproduction management system (iARMS), an assisted reproduction management system that runs through the reproductive cycle and covers patient medical records, medical diagnosis, and treatment plans. Further, it provides marketing services; and engages in the research and development of testing devices, instruments and consumables, as well as software for testing devices and instruments. The company serves hospitals and reproductive clinics. It sells its products through distributors. Suzhou Basecare Medical Corporation Limited was incorporated in 2010 and is headquartered in Suzhou, China.

www.basecare.cn

497

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2170.HK

View More

Performance Overview: 2170.HK

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2170.HK
5.84%
HANG SENG INDEX (^HSI)
16.38%

1-Year Return

2170.HK
27.75%
HANG SENG INDEX (^HSI)
20.48%

3-Year Return

2170.HK
18.31%
HANG SENG INDEX (^HSI)
17.02%

5-Year Return

2170.HK
90.33%
HANG SENG INDEX (^HSI)
1.90%

Compare To: 2170.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2170.HK

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    793.23M

  • Enterprise Value

    407.50M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.45

  • Price/Book (mrq)

    0.64

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -79.25%

  • Return on Assets (ttm)

    -9.38%

  • Return on Equity (ttm)

    -18.68%

  • Revenue (ttm)

    299.11M

  • Net Income Avi to Common (ttm)

    -237.03M

  • Diluted EPS (ttm)

    -0.970

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    687.16M

  • Total Debt/Equity (mrq)

    28.76%

  • Levered Free Cash Flow (ttm)

    -267.63M

Research Analysis: 2170.HK

View More

People Also Watch